Cardiovascular Diseases
The site conducts studies focused on Hypertension, high cardiovascular risk, and the prevention of heart failure in patients with established cardiovascular disease. Research aims to improve blood‑pressure control and reduce major cardiovascular events.
- Uncontrolled and resistant hypertension
- Prevention of heart failure
- Risk reduction of cardiovascular death
- Management of high cardiovascular risk
- Combination therapy with dapagliflozin
Medizinisches Versorgungszentrum Jung GbR integrates these cardiovascular projects within its primary‑care framework to support community health.
Nutritional and Metabolic Diseases
Clinical investigations target abnormal lipid metabolism and glucose regulation, including Hypertriglyceridemia, severe hypertriglyceridemia, and Type 2 Diabetes Mellitus. The goal is to lower triglyceride levels and assess cardiovascular outcomes in metabolic disorders.
- Elevated triglyceride levels
- Severe hypertriglyceridemia
- Metabolic control in diabetes
- Cardiovascular outcomes in diabetic patients
- Combination with GLP‑1 receptor agonists
The clinic’s metabolic research complements its broader preventive health services.
Respiratory Tract Diseases
Ongoing trials address chronic lung conditions, primarily Chronic Obstructive Pulmonary Disease (COPD). Studies evaluate therapies that aim to reduce exacerbations and improve long‑term respiratory health.
- Exacerbation reduction in COPD
- Long‑term management of COPD
- Improving lung function
- Patient‑reported outcomes in respiratory health
These respiratory projects are part of the site’s commitment to comprehensive primary‑care research.
Otorhinolaryngologic Diseases
Research includes the symptomatic treatment of acute pharyngitis, focusing on non‑antibiotic lozenge formulations that relieve sore throat and accelerate recovery.
- Symptomatic relief of sore throat
- Non‑antibiotic lozenge therapy
- Patient comfort and recovery speed
- Safety of topical oral treatments
The department integrates these ENT studies with its broader primary‑care services.
Immune System Phenomena
Several trials explore modulation of the immune system in chronic diseases, such as biologic agents for COPD and novel approaches to inflammatory pathways in cardiovascular risk. The purpose is to assess safety and therapeutic benefit of immune‑targeted interventions.
- Targeting inflammatory pathways in respiratory disease
- Modulating immune response in cardiovascular risk
- Novel biologics for immune‑mediated conditions
These investigations expand the site’s expertise in immunology within everyday clinical practice.
